A biomimetic extracellular matrix for cartilage tissue engineering centered on photocurable gelatin, hyaluronic acid and chondroitin sulfate
Source abstract
Abstract
The development of hydrogels tailored for cartilage tissue engineering has been a research and clinical goal for over a decade. Directing cells towards a chondrogenic phenotype and promoting new matrix formation are significant challenges that must be overcome for the successful application of hydrogels in cartilage tissue therapies. Gelatin-methacrylamide (Gel-MA) hydrogels have shown promise for the repair of some tissues, but have not been extensively investigated for cartilage tissue engineering. We encapsulated human chondrocytes in Gel-MA-based hydrogels, and show that with the incorporation of small quantities of photocrosslinkable hyaluronic acid methacrylate (HA-MA), and to a lesser extent chondroitin sulfate methacrylate (CS-MA), chondrogenesis and mechanical properties can be enhanced. The addition of HA-MA to Gel-MA constructs resulted in more rounded cell morphologies, enhanced chondrogenesis as assessed by gene expression and immunofluorescence, and increased quantity and distribution of the newly synthesized extracellular matrix (ECM) throughout the construct. Consequently, while the compressive moduli of control Gel-MA constructs increased by 26 kPa after 8 weeks culture, constructs with HA-MA and CS-MA increased by 114 kPa. The enhanced chondrogenic differentiation, distribution of ECM, and improved mechanical properties make these materials potential candidates for cartilage tissue engineering applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Proteoglycans and glycosaminoglycans research · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Collagen of articular cartilage10.1186/ar380 ↗
2. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation10.1056/NEJM199410063311401 ↗
3. The effects of intermittent dynamic loading on chondrogenic and osteogenic differentiation of human marrow stromal cells encapsulated in RGD-modified poly(ethylene glycol) hydrogels10.1016/j.actbio.2011.06.031 ↗
4. Autologous chondrocyte implantation for the treatment of cartilage lesions of the knee: a systematic review of randomized studies10.1007/s00167-010-1050-3 ↗
5. Autologous chondrocyte implantation compared with microfracture in the knee—a randomised trial10.2106/00004623-200403000-00001 ↗
6. Deciphering chondrocyte behaviour in matrix-induced autologous chondrocyte implantation to undergo accurate cartilage repair with hyaline matrix10.1016/j.patbio.2012.03.003 ↗
7. Synthesis and characterization of photopolymerized multifunctional hydrogels: water-soluble poly(vinyl alcohol) and chondroitin sulfate macromers for chondrocyte encapsulation10.1021/ma0499324 ↗
8. Strategies for zonal cartilage repair using hydrogels10.1002/mabi.200900176 ↗
9. Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells10.1016/j.matbio.2007.07.002 ↗
10. Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage10.1016/j.biomaterials.2010.10.009 ↗
11. Gene expression and cell differentiation in matrix-associated chondrocyte transplantation grafts: a comparative study10.1016/j.joca.2011.07.004 ↗
12. Cell-laden microengineered gelatin methacrylate hydrogels10.1016/j.biomaterials.2010.03.064 ↗
13. Structural and rheological properties of methacrylamide modified gelatin hydrogels10.1021/bm990017d ↗
14. Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function10.1089/ten.tea.2008.0545 ↗
15. Gelatin-methacrylamide hydrogels as potential biomaterials for fabrication of tissue engineered cartilage constructs10.1002/mabi.201200471 ↗
16. Photocrosslinkable polysaccharides for in situ hydrogel formation10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q ↗
17. Dynamic loading stimulates chondrocyte biosynthesis when encapsulated in charged hydrogels prepared from poly(ethylene glycol) and chondroitin sulfate10.1016/j.matbio.2009.08.004 ↗
18. Dynamic compression improves biosynthesis of human zonal chondrocytes from osteoarthritis patients10.1016/j.joca.2012.04.019 ↗
19. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue10.1016/0304-4165(86)90306-5 ↗
20. EF1 alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells10.1186/1471-2199-11-61 ↗
21. Analysis of cartilage matrix fixed charge density and three-dimensional morphology via contrast-enhanced microcomputed tomography10.1073/pnas.0606406103 ↗
22. Hydrogels for the repair of articular cartilage defects10.1089/ten.teb.2011.0077 ↗
23. CD44: from adhesion molecules to signalling regulators10.1038/nrm1004 ↗
24. Hyaluronan: from extracellular glue to pericellular cue10.1038/nrc1391 ↗
25. ECM production of primary human and bovine chondrocytes in hybrid PEG hydrogels containing type I collagen and hyaluronic acid10.1021/bm3003336 ↗
26. Effects of hyaluronan on engineered articular cartilage extracellular matrix gene expression in 3-dimensional collagen scaffolds10.1002/1097-4636(200104)55:1<13::AID-JBM20>3.0.CO;2-G ↗
27. The effects of hyaluronic acid on articular chondrocytes10.1302/0301-620X.87B8.15083 ↗
28. Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system10.1290/1071-2690(2002)038<0457:CDOHMS>2.0.CO;2 ↗
29. Injectable chitosan hyaluronic acid hydrogels for cartilage tissue engineering10.1016/j.actbio.2012.08.033 ↗
30. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran–hyaluronic acid conjugates for cartilage tissue engineering10.1016/j.biomaterials.2010.01.013 ↗
31. Incorporation of biomimetic matrix molecules in PEG hydrogels enhances matrix deposition and reduces load-induced loss of chondrocyte-secreted matrix10.1002/jbm.a.33057 ↗
32. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels10.1016/0092-8674(82)90027-7 ↗
33. Chondrocyte phenotypes on different extracellular matrix monolayers10.1016/j.biomaterials.2004.01.044 ↗
34. Hyaluronan in morphogenesis10.1046/j.1365-2796.1997.00171.x ↗
35. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells10.1161/01.ATV.19.4.1004 ↗
36. CD44 and integrin matrix receptors participate in cartilage homeostasis10.1007/s00018-002-8403-0 ↗
37. Rapid phenotypic changes in passaged articular chondrocyte subpopulations10.1016/j.orthres.2004.08.008 ↗
38. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure10.1177/0363546509346395 ↗
39. Hyaluronan-binding proteins in development, tissue homeostasis, and disease10.1096/fasebj.7.13.7691670 ↗
40. Comparison of the equilibrium response of articular cartilage in unconfined compression, confined compression and indentation10.1016/S0021-9290(02)00052-0 ↗
41. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function10.1093/oxfordjournals.jbchem.a022166 ↗
42. Levett PA, Melchels FPW, Schrobback K, Hutmacher DW, Malda J, Klein TJ. Chondrocyte redifferentiation and construct mechanical property development in single-component photocrosslinkable hydrogels. J Biomed Mater Res A, 2013. http://dx.doi.org/10.1002/jbm.a.34924.10.1002/jbm.a.34924 ↗
43. High mesenchyrnal stem cell seeding densities in hyaluronic acid hydrogels produce engineered cartilage with native tissue properties10.1016/j.actbio.2012.04.033 ↗
44. Synthesis and characterization of hybrid hyaluronic acid-gelatin hydrogels10.1021/bm3019856 ↗
45. MMP-13 is induced during chondrocyte hypertrophy10.1002/(SICI)1097-4644(20000615)77:4<678::AID-JCB15>3.0.CO;2-P ↗
46. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E ↗
47. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage10.1172/JCI119316 ↗
48. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice10.1074/jbc.M411036200 ↗
49. Integrin α1β1 mediates collagen induction of MMP-13 expression in MC615 chondrocytes
50. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cattilage10.1002/jbm.a.10319 ↗
51. Long-term effects of hydrogel properties on human chondrocyte behavior10.1039/c0sm00229a ↗
52. Response of zonal chondrocytes to extracellular matrix-hydrogels10.1016/j.febslet.2007.07.049 ↗